Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
Tauvid has been approved by the U.S. Food and Drug Administration (FDA) in 2020 for positron emission tomography (PET) imaging of adult patients with cognitive impairments undergoing evaluation for Alzheimer’s disease (AD) based on tau pathology. Abnormal aggregation of tau proteins is one of the ma...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2021-01-01
|
| Colección: | Pharmaceuticals |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1424-8247/14/2/110 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|